

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * eosinophil chemotaxis (GO:0048245) | 9.64525418 |
| 2 | * eosinophil migration (GO:0072677) | 8.52628431 |
| 3 | regulation of mononuclear cell migration (GO:0071675) | 7.60683046 |
| 4 | regulation of macrophage chemotaxis (GO:0010758) | 7.49449996 |
| 5 | cellular response to ethanol (GO:0071361) | 6.39818735 |
| 6 | positive regulation of mast cell degranulation (GO:0043306) | 6.24166735 |
| 7 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 6.24166735 |
| 8 | virion attachment to host cell (GO:0019062) | 6.18122610 |
| 9 | adhesion of symbiont to host cell (GO:0044650) | 6.18122610 |
| 10 | adhesion of symbiont to host (GO:0044406) | 6.08445342 |
| 11 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 5.92710286 |
| 12 | positive regulation of mast cell activation (GO:0033005) | 5.74158027 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 5.64812429 |
| 14 | monocyte chemotaxis (GO:0002548) | 5.61925561 |
| 15 | phagocytosis, recognition (GO:0006910) | 5.40866827 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 5.04392302 |
| 17 | regulation of hypersensitivity (GO:0002883) | 5.01035154 |
| 18 | cellular extravasation (GO:0045123) | 4.95994701 |
| 19 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.87654020 |
| 20 | positive regulation of leukocyte degranulation (GO:0043302) | 4.85639039 |
| 21 | positive regulation of type 2 immune response (GO:0002830) | 4.61681005 |
| 22 | pinocytosis (GO:0006907) | 4.45910125 |
| 23 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.41652601 |
| 24 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.34300824 |
| 25 | regulation of cholesterol storage (GO:0010885) | 4.32134878 |
| 26 | regulation of mast cell degranulation (GO:0043304) | 4.25263788 |
| 27 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.24372782 |
| 28 | B cell mediated immunity (GO:0019724) | 4.24135290 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 4.17232311 |
| 30 | glycosphingolipid catabolic process (GO:0046479) | 4.10831278 |
| 31 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.05022948 |
| 32 | regulation of mast cell activation (GO:0033003) | 3.92844165 |
| 33 | lymphocyte chemotaxis (GO:0048247) | 3.88081483 |
| 34 | regulation of T cell tolerance induction (GO:0002664) | 3.87129895 |
| 35 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.84593442 |
| 36 | T cell migration (GO:0072678) | 3.83587185 |
| 37 | phagocytosis, engulfment (GO:0006911) | 3.79474025 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.75892509 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.71366501 |
| 40 | glycolipid catabolic process (GO:0019377) | 3.70350925 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70346350 |
| 42 | amino sugar catabolic process (GO:0046348) | 3.62906335 |
| 43 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.62250591 |
| 44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.59310427 |
| 45 | positive regulation of lymphocyte migration (GO:2000403) | 3.53975408 |
| 46 | negative regulation of interleukin-12 production (GO:0032695) | 3.53540510 |
| 47 | regulation of lymphocyte migration (GO:2000401) | 3.50950146 |
| 48 | histamine secretion (GO:0001821) | 3.47584729 |
| 49 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.46570142 |
| 50 | myeloid dendritic cell differentiation (GO:0043011) | 3.42287390 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.39748079 |
| 52 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.39710592 |
| 53 | regulation of apoptotic cell clearance (GO:2000425) | 3.37924429 |
| 54 | positive regulation of leukocyte chemotaxis (GO:0002690) | 3.36922298 |
| 55 | * granulocyte chemotaxis (GO:0071621) | 3.35574942 |
| 56 | ceramide catabolic process (GO:0046514) | 3.34072227 |
| 57 | adenosine receptor signaling pathway (GO:0001973) | 3.33340406 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.32044214 |
| 59 | positive regulation of regulated secretory pathway (GO:1903307) | 3.31021300 |
| 60 | positive regulation of macrophage cytokine production (GO:0060907) | 3.29227234 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 3.27548441 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 3.27548441 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.27548441 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.27548441 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.27548441 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 3.27548441 |
| 67 | detection of external biotic stimulus (GO:0098581) | 3.26378893 |
| 68 | T cell mediated immunity (GO:0002456) | 3.25863181 |
| 69 | barbed-end actin filament capping (GO:0051016) | 3.25666344 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.23196181 |
| 71 | T-helper 1 type immune response (GO:0042088) | 3.22772602 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.22663985 |
| 73 | * granulocyte migration (GO:0097530) | 3.20958801 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 3.19972302 |
| 75 | leukocyte mediated cytotoxicity (GO:0001909) | 3.19752589 |
| 76 | membrane invagination (GO:0010324) | 3.19141467 |
| 77 | regulation of granulocyte chemotaxis (GO:0071622) | 3.18970159 |
| 78 | positive regulation of prostaglandin secretion (GO:0032308) | 3.15983577 |
| 79 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.14236515 |
| 80 | folic acid transport (GO:0015884) | 3.13843170 |
| 81 | cellular response to interferon-gamma (GO:0071346) | 3.13730387 |
| 82 | regulation of type 2 immune response (GO:0002828) | 3.13131612 |
| 83 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.13004285 |
| 84 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.11137832 |
| 85 | N-acetylneuraminate metabolic process (GO:0006054) | 3.10679886 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10563738 |
| 87 | myeloid dendritic cell activation (GO:0001773) | 3.08751764 |
| 88 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.06241330 |
| 89 | sphingolipid catabolic process (GO:0030149) | 3.05633020 |
| 90 | regulation of prostaglandin secretion (GO:0032306) | 3.04388999 |
| 91 | positive regulation of leukocyte migration (GO:0002687) | 3.04351189 |
| 92 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01245800 |
| 93 | response to interferon-gamma (GO:0034341) | 3.00462344 |
| 94 | positive regulation of neutrophil migration (GO:1902624) | 2.96550924 |
| 95 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.96550924 |
| 96 | membrane lipid catabolic process (GO:0046466) | 2.93518068 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.92241569 |
| 98 | intracellular pH reduction (GO:0051452) | 2.91895329 |
| 99 | positive regulation of acute inflammatory response (GO:0002675) | 2.91817090 |
| 100 | type I interferon signaling pathway (GO:0060337) | 2.89803759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.79472516 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.43069672 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.39122843 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.84288819 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.96535004 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70008692 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.62837736 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.62178324 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.58456744 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15678587 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00218168 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63338641 |
| 13 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.49476508 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42422824 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41722535 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.38625388 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.33639701 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31802591 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.23301534 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01282969 |
| 21 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.00309144 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99059260 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93934711 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89799862 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.88359444 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.86437308 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79911958 |
| 28 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70737804 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69293086 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68342136 |
| 31 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.61300323 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58501281 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55675884 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55467208 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54775791 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53944849 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46698107 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46495848 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46370079 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44862025 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41419341 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38879829 |
| 43 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34560311 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34264267 |
| 45 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32924594 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27641641 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22881042 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22795882 |
| 49 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22464396 |
| 50 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22055670 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21026095 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16138392 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15962972 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14585181 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13580843 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13006285 |
| 57 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09321613 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09299023 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03867960 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03573110 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01103656 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.00483661 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95644921 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95002322 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92622615 |
| 66 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92371682 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91484506 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91454113 |
| 69 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89639927 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88710747 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86816427 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86798949 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86273430 |
| 74 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85093050 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.83797600 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83769852 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82282204 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81978594 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.80705841 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80681262 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80106182 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80086942 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78290153 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77373903 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76797270 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76432865 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76230775 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74012695 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.73817087 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.73752337 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73342866 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.70296556 |
| 93 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70115239 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.69914346 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69365610 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.68077979 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.66842567 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66599780 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66599780 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65228694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.22365921 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.89246861 |
| 3 | MP0009840_abnormal_foam_cell | 3.87690043 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.62317811 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.59444696 |
| 6 | MP0006082_CNS_inflammation | 3.54765890 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.33925472 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.21603896 |
| 9 | MP0000569_abnormal_digit_pigmentation | 3.02510801 |
| 10 | MP0000343_altered_response_to | 3.00953344 |
| 11 | MP0002419_abnormal_innate_immunity | 2.87556535 |
| 12 | MP0009785_altered_susceptibility_to | 2.79012645 |
| 13 | MP0002277_abnormal_respiratory_mucosa | 2.71229698 |
| 14 | MP0005025_abnormal_response_to | 2.66637159 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.64857756 |
| 16 | MP0001790_abnormal_immune_system | 2.57397565 |
| 17 | MP0005387_immune_system_phenotype | 2.57397565 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.43809382 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.43681930 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 2.41046658 |
| 21 | MP0000604_amyloidosis | 2.39218842 |
| 22 | MP0002723_abnormal_immune_serum | 2.29745171 |
| 23 | MP0003436_decreased_susceptibility_to | 2.21541988 |
| 24 | MP0001800_abnormal_humoral_immune | 2.16384397 |
| 25 | MP0003724_increased_susceptibility_to | 2.15484915 |
| 26 | MP0000015_abnormal_ear_pigmentation | 2.07854435 |
| 27 | MP0005174_abnormal_tail_pigmentation | 2.07284073 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.93914203 |
| 29 | MP0000920_abnormal_myelination | 1.91839102 |
| 30 | MP0001819_abnormal_immune_cell | 1.88854599 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.84751256 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.82964140 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.82393565 |
| 34 | MP0000685_abnormal_immune_system | 1.73650888 |
| 35 | MP0008469_abnormal_protein_level | 1.70523367 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.67114447 |
| 37 | MP0003075_altered_response_to | 1.59882728 |
| 38 | MP0009764_decreased_sensitivity_to | 1.58946445 |
| 39 | MP0008004_abnormal_stomach_pH | 1.52028357 |
| 40 | MP0005310_abnormal_salivary_gland | 1.48872695 |
| 41 | MP0003448_altered_tumor_morphology | 1.43432602 |
| 42 | MP0005365_abnormal_bile_salt | 1.42407941 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.39675963 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.39241446 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.34986801 |
| 46 | MP0003303_peritoneal_inflammation | 1.32013255 |
| 47 | MP0000716_abnormal_immune_system | 1.22894917 |
| 48 | MP0004947_skin_inflammation | 1.20018835 |
| 49 | MP0002405_respiratory_system_inflammati | 1.16318443 |
| 50 | MP0009763_increased_sensitivity_to | 1.13471394 |
| 51 | MP0006054_spinal_hemorrhage | 1.13264057 |
| 52 | MP0005360_urolithiasis | 1.10669986 |
| 53 | MP0000371_diluted_coat_color | 1.09282088 |
| 54 | MP0001727_abnormal_embryo_implantation | 1.07426800 |
| 55 | MP0003690_abnormal_glial_cell | 1.06343048 |
| 56 | MP0003828_pulmonary_edema | 1.04199025 |
| 57 | MP0005647_abnormal_sex_gland | 1.03623838 |
| 58 | MP0000858_altered_metastatic_potential | 0.96104869 |
| 59 | MP0005166_decreased_susceptibility_to | 0.96021440 |
| 60 | MP0002295_abnormal_pulmonary_circulatio | 0.96020026 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 0.94986214 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94833310 |
| 63 | MP0001853_heart_inflammation | 0.94409339 |
| 64 | MP0005164_abnormal_response_to | 0.92566987 |
| 65 | MP0002429_abnormal_blood_cell | 0.91381453 |
| 66 | MP0003279_aneurysm | 0.91061455 |
| 67 | MP0000249_abnormal_blood_vessel | 0.88067559 |
| 68 | MP0002095_abnormal_skin_pigmentation | 0.88063925 |
| 69 | MP0010155_abnormal_intestine_physiology | 0.87892256 |
| 70 | MP0002398_abnormal_bone_marrow | 0.87856497 |
| 71 | MP0000689_abnormal_spleen_morphology | 0.86198453 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.84897676 |
| 73 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84447636 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 0.81522715 |
| 75 | MP0009115_abnormal_fat_cell | 0.81290220 |
| 76 | MP0001851_eye_inflammation | 0.78131886 |
| 77 | MP0008260_abnormal_autophagy | 0.76758311 |
| 78 | MP0009643_abnormal_urine_homeostasis | 0.75787513 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.75049991 |
| 80 | MP0010307_abnormal_tumor_latency | 0.74711390 |
| 81 | MP0000609_abnormal_liver_physiology | 0.68011062 |
| 82 | MP0003315_abnormal_perineum_morphology | 0.67386478 |
| 83 | MP0005165_increased_susceptibility_to | 0.67229858 |
| 84 | MP0008874_decreased_physiological_sensi | 0.67058214 |
| 85 | MP0004883_abnormal_blood_vessel | 0.66260649 |
| 86 | MP0005670_abnormal_white_adipose | 0.64292419 |
| 87 | MP0005390_skeleton_phenotype | 0.63543822 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.63383068 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.63035574 |
| 90 | MP0001324_abnormal_eye_pigmentation | 0.62619814 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.61861239 |
| 92 | MP0003632_abnormal_nervous_system | 0.61674216 |
| 93 | MP0002971_abnormal_brown_adipose | 0.61072456 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.59786352 |
| 95 | MP0004742_abnormal_vestibular_system | 0.58476656 |
| 96 | MP0001542_abnormal_bone_strength | 0.58270112 |
| 97 | MP0002722_abnormal_immune_system | 0.57816363 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.56456759 |
| 99 | MP0003795_abnormal_bone_structure | 0.56196646 |
| 100 | MP0002090_abnormal_vision | 0.55914220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 9.37494749 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.42409478 |
| 3 | Spontaneous hematomas (HP:0007420) | 7.16327769 |
| 4 | Recurrent abscess formation (HP:0002722) | 6.42203585 |
| 5 | Thick nail (HP:0001805) | 6.14868342 |
| 6 | Pustule (HP:0200039) | 5.95831105 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.93243567 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 5.72056311 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.72056311 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.72056311 |
| 11 | Glomerulonephritis (HP:0000099) | 5.43643698 |
| 12 | Premature loss of primary teeth (HP:0006323) | 5.04182709 |
| 13 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 4.76228254 |
| 14 | Osteolytic defects of the hand bones (HP:0009699) | 4.76228254 |
| 15 | Joint hemorrhage (HP:0005261) | 4.60393623 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.45375206 |
| 17 | Recurrent skin infections (HP:0001581) | 4.41722421 |
| 18 | Dysostosis multiplex (HP:0000943) | 4.20369901 |
| 19 | Complement deficiency (HP:0004431) | 4.18828927 |
| 20 | Disinhibition (HP:0000734) | 4.16722386 |
| 21 | Periodontitis (HP:0000704) | 4.13983111 |
| 22 | Axonal loss (HP:0003447) | 4.05753960 |
| 23 | Gingivitis (HP:0000230) | 4.04469263 |
| 24 | Agnosia (HP:0010524) | 3.94255591 |
| 25 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.72162295 |
| 26 | Mutism (HP:0002300) | 3.58220635 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.51990509 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.51990509 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.51990509 |
| 30 | Upper motor neuron abnormality (HP:0002127) | 3.41830424 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.37315312 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.37315312 |
| 33 | Abnormality of complement system (HP:0005339) | 3.15631619 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.15483618 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.15483618 |
| 36 | Nuclear cataract (HP:0100018) | 3.02853679 |
| 37 | Albinism (HP:0001022) | 3.01331826 |
| 38 | Prostate neoplasm (HP:0100787) | 2.95458743 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.87997926 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.87890138 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83404030 |
| 42 | Loss of speech (HP:0002371) | 2.79682057 |
| 43 | Cheilitis (HP:0100825) | 2.75611981 |
| 44 | Nephritis (HP:0000123) | 2.63727150 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62817992 |
| 46 | Pathologic fracture (HP:0002756) | 2.60851577 |
| 47 | Inappropriate behavior (HP:0000719) | 2.60665777 |
| 48 | Abnormality of the alveolar ridges (HP:0006477) | 2.58166321 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.52397176 |
| 50 | Hemoptysis (HP:0002105) | 2.51873031 |
| 51 | Palmoplantar hyperkeratosis (HP:0000972) | 2.50253151 |
| 52 | Personality changes (HP:0000751) | 2.34797496 |
| 53 | Palmar hyperkeratosis (HP:0010765) | 2.32314932 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.30377656 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19935753 |
| 56 | Obstructive lung disease (HP:0006536) | 2.19935753 |
| 57 | Esophageal varix (HP:0002040) | 2.18259813 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.17799675 |
| 59 | Protuberant abdomen (HP:0001538) | 2.15292505 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.15164023 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.13131942 |
| 62 | Apathy (HP:0000741) | 2.10899351 |
| 63 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09364456 |
| 64 | Zonular cataract (HP:0010920) | 2.09155382 |
| 65 | Hydroxyprolinuria (HP:0003080) | 2.06746228 |
| 66 | Abnormality of proline metabolism (HP:0010907) | 2.06746228 |
| 67 | Diminished motivation (HP:0000745) | 2.06407438 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.06255200 |
| 69 | Abnormality of primary teeth (HP:0006481) | 2.02007162 |
| 70 | Tetraparesis (HP:0002273) | 1.99207388 |
| 71 | Epistaxis (HP:0000421) | 1.98159538 |
| 72 | Esophageal neoplasm (HP:0100751) | 1.97624672 |
| 73 | Neoplasm of head and neck (HP:0012288) | 1.97624672 |
| 74 | Urticaria (HP:0001025) | 1.96413740 |
| 75 | Progressive visual loss (HP:0000529) | 1.95324916 |
| 76 | Plantar hyperkeratosis (HP:0007556) | 1.92448512 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 1.91659122 |
| 78 | Peripheral demyelination (HP:0011096) | 1.90782703 |
| 79 | Bone cyst (HP:0012062) | 1.90768053 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 1.89823395 |
| 81 | Bone pain (HP:0002653) | 1.89737281 |
| 82 | Abnormality of the basal ganglia (HP:0002134) | 1.84601331 |
| 83 | Mucosal telangiectasiae (HP:0100579) | 1.81271697 |
| 84 | Pulmonary infiltrates (HP:0002113) | 1.79725769 |
| 85 | Recurrent pneumonia (HP:0006532) | 1.77003013 |
| 86 | Myocardial infarction (HP:0001658) | 1.74470768 |
| 87 | Hepatosplenomegaly (HP:0001433) | 1.73201801 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.71985559 |
| 89 | Memory impairment (HP:0002354) | 1.71375506 |
| 90 | Meningitis (HP:0001287) | 1.71286656 |
| 91 | Neurofibrillary tangles (HP:0002185) | 1.69932933 |
| 92 | Purpura (HP:0000979) | 1.69553524 |
| 93 | Ovoid vertebral bodies (HP:0003300) | 1.64852796 |
| 94 | Metaphyseal irregularity (HP:0003025) | 1.63804420 |
| 95 | Dementia (HP:0000726) | 1.63649671 |
| 96 | Hematochezia (HP:0002573) | 1.63210943 |
| 97 | Amyloidosis (HP:0011034) | 1.61430706 |
| 98 | Malnutrition (HP:0004395) | 1.60207926 |
| 99 | Myositis (HP:0100614) | 1.59604718 |
| 100 | Cardiomegaly (HP:0001640) | 1.59066730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 3.77165752 |
| 2 | CSF1R | 2.70134198 |
| 3 | MAP3K14 | 2.55218060 |
| 4 | CAMK1D | 2.42068210 |
| 5 | EPHB2 | 2.40175635 |
| 6 | TESK2 | 2.31012803 |
| 7 | CAMKK2 | 2.21981716 |
| 8 | JAK1 | 2.08965016 |
| 9 | RIPK4 | 2.06537994 |
| 10 | BLK | 10.5603958 |
| 11 | CAMK1G | 1.90878646 |
| 12 | SYK | 1.87526926 |
| 13 | TGFBR2 | 1.69256616 |
| 14 | ERN1 | 1.68877850 |
| 15 | LYN | 1.63867084 |
| 16 | JAK3 | 1.57991906 |
| 17 | BMPR2 | 1.56864843 |
| 18 | MAP3K13 | 1.55264293 |
| 19 | PDK2 | 1.53655296 |
| 20 | KIT | 1.48389064 |
| 21 | PIK3CG | 1.47448405 |
| 22 | CSK | 1.42797623 |
| 23 | CDK6 | 1.28069975 |
| 24 | FES | 1.25027815 |
| 25 | MAP3K3 | 1.22099811 |
| 26 | FGR | 1.17952194 |
| 27 | KSR1 | 1.15373752 |
| 28 | MAP2K3 | 1.14739921 |
| 29 | ZAP70 | 1.06646516 |
| 30 | GRK7 | 1.01515747 |
| 31 | MAPKAPK5 | 0.97808663 |
| 32 | TXK | 0.94754582 |
| 33 | ITK | 0.88678669 |
| 34 | IKBKB | 0.88657680 |
| 35 | TRPM7 | 0.88251075 |
| 36 | BTK | 0.87593150 |
| 37 | MAPKAPK3 | 0.87013099 |
| 38 | YES1 | 0.82928459 |
| 39 | NEK9 | 0.81183846 |
| 40 | LCK | 0.80199009 |
| 41 | ADRBK1 | 0.77857691 |
| 42 | TBK1 | 0.76287148 |
| 43 | MAP3K1 | 0.74270637 |
| 44 | ADRBK2 | 0.71762075 |
| 45 | JAK2 | 0.71066020 |
| 46 | TAF1 | 0.70402414 |
| 47 | HCK | 0.67490421 |
| 48 | CAMKK1 | 0.64432312 |
| 49 | MAP4K1 | 0.64249778 |
| 50 | ACVR1B | 0.62771565 |
| 51 | MATK | 0.61349728 |
| 52 | PRKCQ | 0.60778513 |
| 53 | PDPK1 | 0.59251318 |
| 54 | IRAK4 | 0.58574777 |
| 55 | MOS | 0.58548497 |
| 56 | RPS6KA2 | 0.58154112 |
| 57 | EGFR | 0.57209369 |
| 58 | TEC | 0.56644287 |
| 59 | IRAK3 | 0.56554321 |
| 60 | IKBKE | 0.55687743 |
| 61 | PRKG2 | 0.55574449 |
| 62 | FYN | 0.55458295 |
| 63 | SGK2 | 0.54538160 |
| 64 | CDK9 | 0.54124205 |
| 65 | ABL2 | 0.53676015 |
| 66 | DMPK | 0.52759689 |
| 67 | SGK3 | 0.51542559 |
| 68 | ARAF | 0.50137629 |
| 69 | ABL1 | 0.49550217 |
| 70 | KSR2 | 0.47314518 |
| 71 | PDK1 | 0.46946467 |
| 72 | TAOK3 | 0.45584341 |
| 73 | MAP3K11 | 0.43531976 |
| 74 | MAP3K2 | 0.41966115 |
| 75 | PRKCD | 0.41964737 |
| 76 | ERBB2 | 0.41048437 |
| 77 | PBK | 0.40106013 |
| 78 | PRKG1 | 0.39148137 |
| 79 | PIK3CA | 0.37882832 |
| 80 | CAMK4 | 0.34293172 |
| 81 | IGF1R | 0.32094967 |
| 82 | MAPK12 | 0.31556750 |
| 83 | TNK2 | 0.31223946 |
| 84 | SCYL2 | 0.30037036 |
| 85 | INSR | 0.28822216 |
| 86 | RPS6KC1 | 0.28681950 |
| 87 | RPS6KL1 | 0.28681950 |
| 88 | MAP2K6 | 0.28143570 |
| 89 | NTRK3 | 0.27948558 |
| 90 | MAP3K4 | 0.26509028 |
| 91 | DAPK2 | 0.26180997 |
| 92 | SRC | 0.25477416 |
| 93 | PIM2 | 0.25132587 |
| 94 | TTN | 0.25122554 |
| 95 | MAP3K8 | 0.23907101 |
| 96 | PRKCA | 0.23872154 |
| 97 | CAMK2A | 0.23653971 |
| 98 | PRKAA2 | 0.23179498 |
| 99 | SMG1 | 0.22991137 |
| 100 | RPS6KA6 | 0.22550669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.63757853 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.24762368 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.90537979 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.60159133 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.45771333 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.22768511 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.00465089 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.96013512 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.94090095 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.79967544 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.69058771 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 2.57399992 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.32537838 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.25007701 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.19925749 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15229240 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12880288 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08694453 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92371545 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86581451 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70985838 |
| 22 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55587566 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.52591817 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.37737665 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35454902 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30429609 |
| 27 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25788831 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24222856 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.13457980 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11729698 |
| 31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.11049955 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97065595 |
| 33 | Malaria_Homo sapiens_hsa05144 | 0.92089320 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88770080 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87885581 |
| 36 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79665528 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77388418 |
| 38 | Measles_Homo sapiens_hsa05162 | 0.76968363 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76893787 |
| 40 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75347227 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73873012 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73641478 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72007699 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 0.66124813 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65285532 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 0.60707636 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59436242 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57951295 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57741373 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54558727 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.54019244 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49172270 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.48882780 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47734626 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44763616 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44581147 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44162869 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.42714029 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.41996775 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41847592 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40101899 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38959400 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37973400 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36696037 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.34525329 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32993745 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31891649 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.31739225 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31453048 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29110179 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28400925 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28084447 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.27908079 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25704463 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25012432 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23244857 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.21982642 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21519936 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20155269 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.19107452 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18688723 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.18081603 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.16847338 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15430962 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.14386647 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11930658 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10087922 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.09715882 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.09402857 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.08250647 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.07394631 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.07352928 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.06474171 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.05856688 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05766215 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04601082 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.03903175 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.03388145 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.01971045 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.01535773 |

